Literature DB >> 10515802

Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.

Y Ogura1, M Kurosaki, Y Asahina, N Enomoto, F Marumo, C Sato.   

Abstract

The prevalence and clinical significance of naturally occurring mutations in the full-length surface and overlapping polymerase genes of hepatitis B virus (HBV) were analyzed in 42 patients with chronic hepatitis. Mutations were observed in 10 patients (24%) in the a determinant region, which is the neutralizing epitope within the major hydrophilic region of the surface gene. A high proportion of these mutations (17/18; 94%) occurred in the first loop, unlike mutations induced by immunization. The presence of serum antibody to hepatitis B surface antigen was significantly associated with these mutations. No other region of the surface gene contained any cluster of mutations. These results suggest that escape mutations commonly contribute to persistency in the natural course of HBV infection. In contrast, mutations affecting the major catalytic domains of the polymerase gene, which could alter susceptibility to antiviral nucleoside analogues, were not detected at all.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515802     DOI: 10.1086/315094

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Public versus personal serotypes of a viral quasispecies.

Authors:  Lukas Hunziker; Adrian Ciurea; Mike Recher; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

2.  A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis.

Authors:  Xu Yang; Xiao-Peng Tang; Jian-Hua Lei; Hong-Yu Luo; Yong-Hong Zhang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies.

Authors:  María L Cuestas; Verónica L Mathet; Vanesa Ruiz; María L Minassian; Cintia Rivero; Andrea Sala; Daniel Corach; Analía Alessio; Marcia Pozzati; Bernardo Frider; José R Oubiña
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 4.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

5.  Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.

Authors:  Hai-Ying Lu; Zheng Zeng; Xiao-Yuan Xu; Nai-Lin Zhang; Min Yu; Wei-Bo Gong
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

6.  Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants.

Authors:  Olivier Lada; Yves Benhamou; Thierry Poynard; Vincent Thibault
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 7.  Combination chemotherapy for hepatitis B virus: the path forward?

Authors:  T Shaw; S Locarnini
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

8.  A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier.

Authors:  Wenbin Tong; Li Sun; Jilan He; Shusen He; Fei Du
Journal:  Virol J       Date:  2010-05-22       Impact factor: 4.099

Review 9.  Hepatitis B virus mutations related to liver disease progression of Korean patients.

Authors:  Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients.

Authors:  Jinxin Zheng; Zheng Zeng; Duyi Zhang; Yanyan Yu; Fang Wang; Calvin Q Pan
Journal:  Liver Int       Date:  2012-08-13       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.